Dr. Casulo on Predicting Outcomes in Follicular Lymphoma

Carla Casulo, MD
Published: Saturday, Mar 02, 2019



Carla Casulo, MD, associate professor, Department of Medicine, University of Rochester Medical Center, discusses several different factors that can help predict outcomes in patients with follicular lymphoma.

At the time of diagnosis, the Follicular Lymphoma International Prognostic Index (FLIPI) and FLIPI2 scores can assist physicians in predicting response to therapy. In addition, epigenetic markers can be combined with clinical factors to predict whether patients will have worse or better outcomes; this is called the M7FLIPI.

<<< 2019 International Congress on Hematologic Malignancies


Carla Casulo, MD, associate professor, Department of Medicine, University of Rochester Medical Center, discusses several different factors that can help predict outcomes in patients with follicular lymphoma.

At the time of diagnosis, the Follicular Lymphoma International Prognostic Index (FLIPI) and FLIPI2 scores can assist physicians in predicting response to therapy. In addition, epigenetic markers can be combined with clinical factors to predict whether patients will have worse or better outcomes; this is called the M7FLIPI.

<<< 2019 International Congress on Hematologic Malignancies

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication
x